Orbimed Advisors as of June 30, 2019
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 123 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 6.9 | $443M | 3.8M | 115.15 | |
Tricida | 6.8 | $439M | 11M | 39.46 | |
Boston Scientific Corporation (BSX) | 4.5 | $290M | 6.8M | 42.98 | |
Alexion Pharmaceuticals | 3.9 | $252M | 1.9M | 130.98 | |
Alector (ALEC) | 3.9 | $251M | 13M | 19.00 | |
Merck & Co (MRK) | 3.3 | $216M | 2.6M | 83.85 | |
Prevail Therapeutics Ord | 2.8 | $183M | 14M | 13.20 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.8 | $179M | 973k | 183.38 | |
Neurocrine Biosciences (NBIX) | 2.4 | $155M | 1.8M | 84.43 | |
Iovance Biotherapeutics (IOVA) | 2.1 | $136M | 5.5M | 24.52 | |
Thermo Fisher Scientific (TMO) | 2.1 | $136M | 463k | 293.68 | |
Edwards Lifesciences (EW) | 2.0 | $132M | 715k | 184.74 | |
Sarepta Therapeutics (SRPT) | 1.9 | $126M | 828k | 151.95 | |
Wright Medical Group Nv | 1.9 | $125M | 4.2M | 29.82 | |
Intuitive Surgical (ISRG) | 1.7 | $110M | 210k | 524.55 | |
Turning Point Therapeutics I | 1.6 | $105M | 2.6M | 40.70 | |
Anthem (ELV) | 1.6 | $102M | 362k | 282.21 | |
Ptc Therapeutics I (PTCT) | 1.5 | $94M | 2.1M | 45.00 | |
Bausch Health Companies (BHC) | 1.5 | $94M | 3.7M | 25.22 | |
Natera (NTRA) | 1.4 | $89M | 3.2M | 27.58 | |
Inspire Med Sys (INSP) | 1.4 | $89M | 1.5M | 60.65 | |
Bristol Myers Squibb (BMY) | 1.3 | $84M | 1.8M | 45.35 | |
Exelixis (EXEL) | 1.3 | $84M | 3.9M | 21.37 | |
Logicbio Therapeutics | 1.3 | $84M | 6.5M | 13.00 | |
Avedro | 1.3 | $83M | 4.2M | 19.64 | |
Deciphera Pharmaceuticals | 1.3 | $82M | 3.6M | 22.55 | |
Abbott Laboratories (ABT) | 1.2 | $79M | 938k | 84.10 | |
eHealth (EHTH) | 1.2 | $78M | 910k | 86.10 | |
Athenex | 1.2 | $76M | 3.8M | 19.80 | |
Synthorx | 1.1 | $72M | 5.3M | 13.51 | |
Uniqure Nv (QURE) | 1.1 | $70M | 898k | 78.15 | |
Meiragtx Holdings (MGTX) | 1.1 | $70M | 2.6M | 26.88 | |
Regeneron Pharmaceuticals (REGN) | 1.1 | $68M | 216k | 313.00 | |
Agilent Technologies Inc C ommon (A) | 1.0 | $67M | 893k | 74.67 | |
Audentes Therapeutics | 1.0 | $65M | 1.7M | 37.86 | |
Arvinas Ord (ARVN) | 0.9 | $59M | 2.7M | 21.99 | |
Principia Biopharma | 0.8 | $53M | 1.6M | 33.19 | |
Illumina (ILMN) | 0.8 | $52M | 140k | 368.15 | |
Crinetics Pharmaceuticals In (CRNX) | 0.8 | $51M | 2.0M | 25.00 | |
Restorbio | 0.8 | $49M | 4.8M | 10.20 | |
Apellis Pharmaceuticals (APLS) | 0.8 | $48M | 1.9M | 25.34 | |
Myokardia | 0.7 | $48M | 955k | 50.14 | |
Viewray (VRAYQ) | 0.7 | $45M | 5.1M | 8.81 | |
Argenx Se (ARGX) | 0.7 | $44M | 310k | 141.58 | |
Zai Lab (ZLAB) | 0.6 | $41M | 1.2M | 34.87 | |
Nextcure (NXTC) | 0.6 | $41M | 2.7M | 14.98 | |
Cigna Corp (CI) | 0.6 | $40M | 253k | 157.55 | |
Dex (DXCM) | 0.6 | $39M | 263k | 149.84 | |
Tandem Diabetes Care (TNDM) | 0.6 | $37M | 571k | 64.52 | |
Gilead Sciences (GILD) | 0.5 | $34M | 502k | 67.56 | |
Prothena (PRTA) | 0.5 | $32M | 3.1M | 10.57 | |
Harpoon Therapeutics | 0.5 | $32M | 2.4M | 13.00 | |
Takeda Pharmaceutical (TAK) | 0.5 | $31M | 1.8M | 17.70 | |
Caredx (CDNA) | 0.5 | $30M | 828k | 35.99 | |
Obseva Sa | 0.5 | $30M | 2.6M | 11.31 | |
Spdr S&p 500 Etf (SPY) | 0.5 | $29M | 100k | 293.00 | |
Clovis Oncology | 0.4 | $28M | 1.9M | 14.87 | |
Xtant Med Hldgs (XTNT) | 0.4 | $28M | 9.2M | 3.00 | |
Mylan Nv | 0.4 | $26M | 1.4M | 19.04 | |
Krystal Biotech (KRYS) | 0.4 | $26M | 642k | 40.27 | |
Endo International | 0.4 | $25M | 6.2M | 4.12 | |
Corvus Pharmaceuticals (CRVS) | 0.4 | $25M | 6.6M | 3.74 | |
Aurinia Pharmaceuticals (AUPH) | 0.4 | $23M | 3.5M | 6.58 | |
Adverum Biotechnologies | 0.4 | $23M | 2.0M | 11.89 | |
Amgen (AMGN) | 0.3 | $23M | 122k | 184.28 | |
Spark Therapeutics | 0.3 | $23M | 220k | 102.38 | |
Kala Pharmaceuticals | 0.3 | $22M | 3.4M | 6.38 | |
Genfit S A ads (GNFT) | 0.3 | $22M | 1.1M | 19.75 | |
Alcon (ALC) | 0.3 | $22M | 351k | 61.71 | |
Biogen Idec (BIIB) | 0.3 | $21M | 88k | 233.87 | |
Si-bone (SIBN) | 0.3 | $20M | 985k | 20.34 | |
Karyopharm Therapeutics (KPTI) | 0.3 | $19M | 3.1M | 5.99 | |
Synlogic | 0.3 | $19M | 2.0M | 9.10 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $17M | 787k | 22.00 | |
Verrica Pharmaceuticals (VRCA) | 0.3 | $17M | 1.5M | 11.62 | |
Novo Nordisk A/S (NVO) | 0.3 | $17M | 330k | 51.04 | |
Sinovac Biotech | 0.3 | $17M | 2.8M | 5.85 | |
Alpine Immune Sciences | 0.2 | $16M | 3.7M | 4.21 | |
Abbvie (ABBV) | 0.2 | $15M | 200k | 72.72 | |
Aeglea Biotherapeutics | 0.2 | $15M | 2.2M | 6.85 | |
Amarin Corporation (AMRN) | 0.2 | $14M | 718k | 19.39 | |
X4 Pharmaceuticals (XFOR) | 0.2 | $14M | 937k | 15.00 | |
BioMarin Pharmaceutical (BMRN) | 0.2 | $13M | 150k | 85.65 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $13M | 1.4M | 9.10 | |
Foamix Pharmaceuticals | 0.2 | $12M | 5.2M | 2.38 | |
Immunomedics | 0.2 | $11M | 818k | 13.87 | |
Pfizer (PFE) | 0.2 | $11M | 250k | 43.32 | |
Stryker Corporation (SYK) | 0.2 | $11M | 54k | 205.57 | |
ArQule | 0.2 | $11M | 1.0M | 11.01 | |
Nabriva Therapeutics | 0.2 | $11M | 4.6M | 2.43 | |
Scpharmaceuticals (SCPH) | 0.2 | $11M | 3.4M | 3.19 | |
Constellation Pharmceticls I | 0.2 | $10M | 836k | 12.28 | |
Reata Pharmaceuticals Inc Cl A | 0.1 | $9.4M | 100k | 94.35 | |
Personalis Ord (PSNL) | 0.1 | $8.1M | 300k | 27.15 | |
Puma Biotechnology (PBYI) | 0.1 | $7.9M | 624k | 12.71 | |
Mersana Therapeutics (MRSN) | 0.1 | $7.7M | 1.9M | 4.05 | |
Assembly Biosciences | 0.1 | $7.1M | 524k | 13.49 | |
Amicus Therapeutics (FOLD) | 0.1 | $6.5M | 518k | 12.48 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $6.3M | 635k | 9.86 | |
Arena Pharmaceuticals | 0.1 | $6.4M | 110k | 58.63 | |
Verona Pharma Plc ads (VRNA) | 0.1 | $6.4M | 1.3M | 5.10 | |
Medicines Company | 0.1 | $5.5M | 152k | 36.47 | |
Spero Therapeutics (SPRO) | 0.1 | $5.8M | 508k | 11.51 | |
Adaptive Biotechnologies Cor (ADPT) | 0.1 | $5.8M | 120k | 48.30 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $5.1M | 80k | 63.50 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $5.4M | 1.4M | 4.02 | |
Intellia Therapeutics (NTLA) | 0.1 | $5.4M | 328k | 16.37 | |
Selecta Biosciences | 0.1 | $5.2M | 2.9M | 1.79 | |
Cti Biopharma | 0.1 | $4.3M | 5.0M | 0.86 | |
Aerpio Pharmaceuticals | 0.1 | $4.7M | 5.2M | 0.91 | |
Menlo Therapeutics | 0.1 | $4.0M | 674k | 5.99 | |
Stoke Therapeutics (STOK) | 0.1 | $3.8M | 130k | 29.17 | |
Novus Therapeutics | 0.1 | $3.2M | 3.2M | 1.01 | |
ACADIA Pharmaceuticals (ACAD) | 0.0 | $2.7M | 102k | 26.73 | |
Dynavax Technologies (DVAX) | 0.0 | $2.3M | 584k | 3.99 | |
Realm Therapeutics | 0.0 | $2.9M | 1.0M | 2.81 | |
Marinus Pharmaceuticals | 0.0 | $1.7M | 398k | 4.15 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $2.0M | 212k | 9.31 | |
Avrobio Ord (AVRO) | 0.0 | $1.7M | 106k | 16.26 | |
Flexion Therapeutics | 0.0 | $1.1M | 90k | 12.30 | |
Nuvectra | 0.0 | $1.2M | 350k | 3.35 | |
Biolinerx Ltd-spons | 0.0 | $374k | 1.0M | 0.36 | |
Medigus | 0.0 | $37k | 15k | 2.47 |